These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
505 related items for PubMed ID: 15937305
21. Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT. Rahbar K, Seifarth H, Schäfers M, Stegger L, Hoffmeier A, Spieker T, Tiemann K, Maintz D, Scheld HH, Schober O, Weckesser M. J Nucl Med; 2012 Jun; 53(6):856-63. PubMed ID: 22577239 [Abstract] [Full Text] [Related]
22. 18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer. Shammas A, Degirmenci B, Mountz JM, McCook BM, Branstetter B, Bencherif B, Joyce JM, Carty SE, Kuffner HA, Avril N. J Nucl Med; 2007 Feb; 48(2):221-6. PubMed ID: 17268018 [Abstract] [Full Text] [Related]
23. An FDG-PET/CT-positive lesion mimicking local recurrence of colon cancer 5 years after radical colectomy. Orii T, Okumura M, Yoshimura M, Kitahara H, Karasawa Y. Am J Case Rep; 2015 Mar 12; 16():149-52. PubMed ID: 25761604 [Abstract] [Full Text] [Related]
24. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG. Chen W, Cloughesy T, Kamdar N, Satyamurthy N, Bergsneider M, Liau L, Mischel P, Czernin J, Phelps ME, Silverman DH. J Nucl Med; 2005 Jun 12; 46(6):945-52. PubMed ID: 15937304 [Abstract] [Full Text] [Related]
26. Differentiating benign and malignant pulmonary lesions with FDG-PET. Yang SN, Liang JA, Lin FJ, Kwan AS, Kao CH, Shen YY. Anticancer Res; 2001 Jun 12; 21(6A):4153-7. PubMed ID: 11911310 [Abstract] [Full Text] [Related]
27. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer. Finkelstein SE, Grigsby PW, Siegel BA, Dehdashti F, Moley JF, Hall BL. Ann Surg Oncol; 2008 Jan 12; 15(1):286-92. PubMed ID: 17882493 [Abstract] [Full Text] [Related]
28. Diagnostic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer. Khan N, Oriuchi N, Yoshizaki A, Kanuma T, Higuchi T, Endo K. Ann Nucl Med; 2005 Apr 12; 19(2):137-45. PubMed ID: 15909494 [Abstract] [Full Text] [Related]
34. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors. Gayed I, Vu T, Iyer R, Johnson M, Macapinlac H, Swanston N, Podoloff D. J Nucl Med; 2004 Jan 12; 45(1):17-21. PubMed ID: 14734662 [Abstract] [Full Text] [Related]
38. Regional PET/CT after water gastric inflation for evaluating loco-regional disease of gastric cancer. Lee SJ, Lee WW, Yoon HJ, Lee HY, Lee KH, Kim YH, Park DJ, Kim HH, So Y, Kim SE. Eur J Radiol; 2013 Jun 12; 82(6):935-42. PubMed ID: 23410909 [Abstract] [Full Text] [Related]
40. Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results. Sun L, Su XH, Guan YS, Pan WM, Luo ZM, Wei JH, Wu H. World J Gastroenterol; 2008 Aug 07; 14(29):4627-32. PubMed ID: 18698676 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]